Rein Therapeutics, Inc. - Common Stock, $0.001 par value per share (RNTX)

CUSIP: 00887A204

Q4 2025 13F Holders as of 31 Dec 2025

Security type / class
Equity / Common Stock, $0.001 par value per share
Total 13F shares
10,799,701
Total 13F value
$12,545,188
Holder snapshot 6 signals
Share change
+2,314,808
SEC-reported price per share
$1.16
Number of holders
46
Value change
+$2,685,239
Number of buys
25
Number of sells
9
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
84,905,660

Security key

00887A204

Report period

Q4 2025

Institutions

46

Top holders

10

RNTX full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2026 Previous quarter: Q3 2025 Rein Therapeutics, Inc. SEC filings Rein Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of RNTX - Rein Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
UNIVERSITY OF TEXAS/TEXAS...
Disclosed value leader
UNIVERSITY OF TEXAS/TEXAS...
Comparable rows
15/15
Latest evidence
30 Sep 2025
3/4/5 13D/G 13F Lead comparable stake: 4.4% 13D/G row: UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO Showing 1-6 of 15 holder rows.

Quick read

UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO leads the comparable SEC ownership view at 4.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's linked filing trail.
Comparable ownership Top 5
UNIVERSITY OF TEXAS/TEXAS AM INVE... 4.4%
Voss Capital, LP 1.7%
BIOS Capital Management, LP 2%
VANGUARD GROUP INC 1.4%
Prosight Management, LP 0.67%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
3/4/5 13D/G 13F
10%+ Owner · Company
3/4/5 13D/G 13F
4.4%
from 13D/G
$5,676,284
1,746,549 shares
 — 14 Jun 2024
Voss Capital, LP
13F 3/4/5
Company · 10%+ Owner
13F 3/4/5
1.7%
from 3/4/5
$3,053,179
2,666,532 shares
 — 30 Sep 2025
BIOS Capital Management, LP
13F
Company
13F
2%
$1,944,364
1,690,751 shares
 — 30 Sep 2025
VANGUARD GROUP INC
13F
Company
13F
1.4%
$1,337,826
1,168,407 shares
 — 30 Sep 2025
Prosight Management, LP
13F
Company
13F
0.67%
$650,243
567,898 shares
 — 30 Sep 2025
Cable Car Capital, LP
13F
Company
13F
0.49%
$480,900
420,000 shares
 — 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
46
Shares
10,799,701
Rows available
46
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
39
Q4 2025 holders
46
Holder diff
7
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .